Sökning: onr:"swepub:oai:lup.lub.lu.se:e903cbb0-7ac8-4f3e-be29-4a080038e5ae" > Consensus perspecti...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03457naa a2200517 4500 | |
001 | oai:lup.lub.lu.se:e903cbb0-7ac8-4f3e-be29-4a080038e5ae | |
003 | SwePub | |
008 | 160401s2003 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/1132152 URI |
024 | 7 | a https://doi.org/10.1046/j.1365-2516.9.s1.17.x2 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Berntorp, Eriku Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups4 aut0 (Swepub:lu)medf-ebe |
245 | 1 0 | a Consensus perspectives on prophylactic therapy for haemophilia: summary statement. |
264 | c 2003-04-22 | |
264 | 1 | b Wiley,c 2003 |
338 | a electronic2 rdacarrier | |
520 | a Participants in an international conference on prophylactic therapy for severe haemophilia developed a consensus summary of the findings and conclusions of the conference. In the consensus, participants agreed upon revised definitions for primary and secondary prophylaxis and also made recommendations concerning the need for an international system of pharmacovigilance. Considerations on starting prophylaxis, monitoring outcomes, and individualizing treatment regimens were discussed. Several research questions were identified as needing further investigation, including when to start and when to stop prophylaxis, optimal dosing and dose interval, and methods for assessment of long-term treatment effects. Such studies should include carefully defined cohorts, validated orthopaedic and quality-of-life assessment instruments, and cost-benefit analyses. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng |
700 | 1 | a Astermark, Janu Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups4 aut0 (Swepub:lu)medf-jas |
700 | 1 | a Björkman, S4 aut |
700 | 1 | a Blanchette, V. S.4 aut |
700 | 1 | a Fischer, K.4 aut |
700 | 1 | a Giangrande, P. L. F.4 aut |
700 | 1 | a Gringeri, A.4 aut |
700 | 1 | a Ljung, Rolfu Lund University,Lunds universitet,Enheten för pediatrisk hematologi,Forskargrupper vid Lunds universitet,Paediatric Hematologic Research Group,Lund University Research Groups4 aut0 (Swepub:lu)pedi-rlj |
700 | 1 | a Manco-Johnson, M. J.4 aut |
700 | 1 | a Morfini, M.4 aut |
700 | 1 | a Kilcoyne, R. F.4 aut |
700 | 1 | a Petrini, P.4 aut |
700 | 1 | a Rodriguez-Merchan, E. C.4 aut |
700 | 1 | a Schramm, W.4 aut |
700 | 1 | a Shapiro, A.4 aut |
700 | 1 | a M Van Den Berg, H.4 aut |
700 | 1 | a Hart, C.4 aut |
710 | 2 | a Klinisk koagulationsmedicin, Malmöb Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Haemophiliad : Wileyg 9:Suppl 1, s. 41278-41278q 9:Suppl 1<41278-41278x 1351-8216 |
856 | 4 | u https://portal.research.lu.se/files/2883903/623733.pdfx primaryx freey FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1046/j.1365-2516.9.s1.17.xy FULLTEXT |
856 | 4 | u https://lup.lub.lu.se/search/files/2883903/623733.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/113215 |
856 | 4 8 | u https://doi.org/10.1046/j.1365-2516.9.s1.17.x |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.